Fny Investment Advisers, LLC Exact Sciences Corp Transaction History

Fny Investment Advisers, LLC

  • $208 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 10, 2020
SELL
$77.66 - $99.74 $201,916 - $259,324
-2,600 Closed
0 $0
Q3 2019

Oct 25, 2019
BUY
$90.37 - $122.49 $234,962 - $318,474
2,600 New
2,600 $234,000
Q1 2019

Apr 17, 2019
SELL
$61.98 - $96.5 $10,598 - $16,501
-171 Closed
0 $0
Q4 2018

Jan 22, 2019
BUY
$56.04 - $82.66 $9,582 - $14,134
171 New
171 $10,000

Others Institutions Holding EXAS

# of Institutions
672
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.76B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email